Literature DB >> 12641504

Non-steroidal anti-inflammatory drugs, aspirin and newly diagnosed colitis: a case-control study.

M H Gleeson1, A J M Davis.   

Abstract

BACKGROUND: There have been a number of reports of colitis following exposure to non-steroidal anti-inflammatory drugs (NSAIDs) and salicylates. AIM: To conduct a case-control analysis of new cases of colitis, with particular reference to the usage of NSAIDs and salicylates prior to the development of the disease.
METHODS: One hundred and five consecutive new cases of colitis presenting to a single gastroenterologist were questioned about their recent usage of NSAIDs and salicylates. For comparison, the frequency of usage of these compounds was studied in two groups of 105 age- and sex-matched controls taken from hospital in-patients and community cases attending the Accident and Emergency Department.
RESULTS: Of the 105 cases of colitis studied, 78 patients (74%) had been taking NSAIDs or salicylates prior to or during the development of their disease. By comparison, 20% of community controls were using NSAIDs or salicylates (P < 0.001) and 30% of hospital in-patients were taking these compounds (P < 0.001). Comparison of these frequencies with those of the colitis group gave odds ratios of 9.1 (4.5, 21.9) with the community controls and 6.2 (3.2, 13.5) with the hospital controls.
CONCLUSIONS: In new patients presenting with colitis, there is a significantly high frequency of antecedent exposure to NSAIDs or salicylates, supporting the concept that these agents may be important in the pathogenesis of colitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12641504     DOI: 10.1046/j.1365-2036.2003.01519.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  15 in total

Review 1.  Pathology of drug-associated gastrointestinal disease.

Authors:  Ashley B Price
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

2.  Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn's disease and ulcerative colitis exacerbation.

Authors:  O O Moninuola; W Milligan; P Lochhead; H Khalili
Journal:  Aliment Pharmacol Ther       Date:  2018-04-05       Impact factor: 8.171

Review 3.  Adverse effects of nonsteroidal anti-inflammatory drugs on the colon.

Authors:  Anne Ballinger
Journal:  Curr Gastroenterol Rep       Date:  2008-10

Review 4.  Familial aggregation in inflammatory bowel disease: is it genes or environment?

Authors:  Tiago Nunes; Gionata Fiorino; Silvio Danese; Miquel Sans
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

5.  Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use.

Authors:  Adam M Berg; Aamir N Dam; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-12

6.  Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study.

Authors:  Ashwin N Ananthakrishnan; Leslie M Higuchi; Edward S Huang; Hamed Khalili; James M Richter; Charles S Fuchs; Andrew T Chan
Journal:  Ann Intern Med       Date:  2012-03-06       Impact factor: 25.391

7.  Managing pain in inflammatory bowel disease.

Authors:  Michael J Docherty; R Carter W Jones; Mark S Wallace
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-09

Review 8.  Influence of environmental factors in the development of inflammatory bowel diseases.

Authors:  Evangelia Legaki; Maria Gazouli
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

9.  Risk factors associated with the development of ischemic colitis.

Authors:  Joaquín Cubiella Fernández; Luisa Núñez Calvo; Elvira González Vázquez; Maria Jesús García García; Maria Teresa Alves Pérez; Isabel Martínez Silva; Javier Fernández Seara
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

10.  Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease.

Authors:  Ryan Ungaro; Helena L Chang; Justin Côté-Daigneault; Saurabh Mehandru; Ashish Atreja; Jean-Frederic Colombel
Journal:  Am J Gastroenterol       Date:  2016-06-14       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.